Phase 3 Readout
FLNA: Phase 3 Topline: Haploidentical Allogeneic Peripheral Blood Transplantation: Clinical Trial and Laboratory Correlates
October 17, 2026. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- October 17, 2026
- Company
- Filana Therapeutics Inc. (FLNA)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: Haploidentical Allogeneic Peripheral Blood Transplantation: Clinical Trial and Laboratory Correlates
- Indication
- Myelofibrosis; Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia